Literature DB >> 33488732

Subglottic Stenosis in Children: Preliminary Experience from a Tertiary Care Hospital.

Manzoor Ahmad Latoo1, Aleena Shafi Jallu1.   

Abstract

INTRODUCTION: This retrospective study describes our experience in the evaluation and management of infants with subglottic stenosis.
MATERIALS AND METHODS: The study included 10 patients aged between 1 wk and 18 months with 6 cases having congenital subglottic stenosis and 4 cases having acquired subglottic stenosis.
RESULTS: 6 patients had grade I, 3 patients had grade II, and 1 patient had grade III subglottic stenosis. Tracheostomy was required in 4 patients at the time of presentation. 7 patients were treated successfully with Bougie dilation followed by topical application of mitomycin, whereas 1 patient who failed to serial dilation needed open reconstructive procedure. Laser excision of the anterior subglottic web was performed in one patient. Another patient with underlying cerebral palsy could not be operated upon and was managed with tracheostomy.
CONCLUSION: Subglottic stenosis may be effectively man-aged with endoscopic surgical techniques, although the number of such sittings required varies with the type and severity of stenosis. Open surgical procedures need to be individualised as per the needs of the patient only after all the other endoscopic possibilities have been exhausted.
Copyright © 2020 Manzoor Ahmad Latoo and Aleena Shafi Jallu.

Entities:  

Year:  2020        PMID: 33488732      PMCID: PMC7803111          DOI: 10.1155/2020/6383568

Source DB:  PubMed          Journal:  Int J Otolaryngol        ISSN: 1687-9201


  31 in total

1.  Paediatric subglottic stenosis.

Authors:  A P Bath; A Panarese; M Thevasagayam; P D Bull
Journal:  Clin Otolaryngol Allied Sci       Date:  1999-04

2.  Balloon dilation for recurrent stenosis after pediatric laryngotracheoplasty.

Authors:  John P Bent; Maulik B Shah; Ryan Nord; Sanjay R Parikh
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-09       Impact factor: 1.547

3.  Cricotracheal resection in children weighing less than 10 kg.

Authors:  Erea-Noël Garabedian; Richard Nicollas; Gilles Roger; Jerôme Delattre; Patrick Froehlich; Jean-Michel Triglia
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-06

4.  Effect of exposure to mitomycin C on cultured tympanic membrane fibroblasts.

Authors:  Chul Ho Jang; Chang-Hun Song; Sok Cheon Pak
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-02       Impact factor: 1.675

5.  Undersedation is a risk factor for the development of subglottic stenosis in intubated children.

Authors:  Cláudia Schweiger; Denise Manica; Denise Rotta Rutkay Pereira; Paulo Roberto Antonacci Carvalho; Jefferson Pedro Piva; Gabriel Kuhl; Leo Sekine; Paulo José Cauduro Marostica
Journal:  J Pediatr (Rio J)       Date:  2017-01-25       Impact factor: 2.197

6.  Subglottic stenosis.

Authors:  G Marshak; K M Grundfast
Journal:  Pediatr Clin North Am       Date:  1981-11       Impact factor: 3.278

7.  Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial.

Authors:  C J Hartnick; B E Hartley; P D Lacy; J Liu; J A Bean; J P Willging; C M Myer; R T Cotton
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-10

8.  Pediatric cricotracheal resection: surgical outcomes and risk factor analysis.

Authors:  David R White; Robin T Cotton; Judy A Bean; Michael J Rutter
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-10

9.  Sinus surgery: does mitomycin C reduce stenosis?

Authors:  D R Ingrams; M S Volk; B S Biesman; M M Pankratov; S M Shapshay
Journal:  Laryngoscope       Date:  1998-06       Impact factor: 3.325

10.  Accuracy of stridor-based diagnosis of post-intubation subglottic stenosis in pediatric patients.

Authors:  Cláudia Schweiger; Larissa Valency Eneas; Denise Manica; Cátia de Souza Saleh Netto; Paulo Roberto Antonacci Carvalho; Jefferson Pedro Piva; Gabriel Kuhl; Paulo José Cauduro Marostica
Journal:  J Pediatr (Rio J)       Date:  2018-09-21       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.